Gene · 23765
Papers3,930
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
561 to 580 of 3,930
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Interleukine-17 Cytokine Family: Role in Development and Progression of Spondyloarthritis, Current and Potential Therapeutic Inhibitors. | Biomedicines | 2023 | 37238999 | PubTator, text mining | PubMed |
| A Brief Overview of Neutrophils in Neurological Diseases. | Biomolecules | 2023 | 37238612 | PubTator, text mining | PubMed |
| IL5RA as an immunogenic cell death-related predictor in progression and therapeutic response of multiple myeloma. | Sci Rep | 2023 | 37236993 | PubTator, text mining | PubMed |
| Current Molecular, Cellular and Genetic Aspects of Peri-Implantitis Disease: A Narrative Review. | Dent J (Basel) | 2023 | 37232785 | PubTator, text mining | PubMed |
| Is Th17-Targeted Therapy Effective in Systemic Lupus Erythematosus? | Curr Issues Mol Biol | 2023 | 37232744 | PubTator, text mining | PubMed |
| FAM3C/ILEI protein is elevated in psoriatic lesions and triggers psoriasiform hyperproliferation in mice. | EMBO Mol Med | 2023 | 37226685 | PubTator, text mining | PubMed |
| Autophagy modulators influence the content of important signalling molecules in PS-positive extracellular vesicles. | Cell Commun Signal | 2023 | 37226246 | PubTator, text mining | PubMed |
| A publication-wide association study (PWAS), historical language models to prioritise novel therapeutic drug targets. | Sci Rep | 2023 | 37225853 | PubTator, text mining | PubMed |
| Extensive cytokine biomarker analysis in serum of Guillain-Barré syndrome patients. | Sci Rep | 2023 | 37221406 | PubTator, text mining | PubMed |
| iPSC-derived reactive astrocytes from patients with multiple sclerosis protect cocultured neurons in inflammatory conditions. | J Clin Invest | 2023 | 37219933 | PubTator, text mining | PubMed |
| A novel immunogenic cell death-related subtype classification and risk signature for predicting prognosis and immunotherapy efficacy in gastric cancer. | Front Immunol | 2023 | 37215130 | PubTator, text mining | PubMed |
| Sex-biased immunological processes drive hidradenitis suppurativa. | Front Immunol | 2023 | 37215102 | PubTator, text mining | PubMed |
| Intrinsically bioactive and biomimetic nanoparticle-derived therapies alleviate asthma by regulating multiple pathological cells. | Bioact Mater | 2023 | 37214258 | PubTator, text mining | PubMed |
| IL-17A-mediated mitochondrial dysfunction induces pyroptosis in colorectal cancer cells and promotes CD8 + T-cell tumour infiltration. | J Transl Med | 2023 | 37211606 | PubTator, text mining | PubMed |
| Unfolded protein response factor ATF6 augments T helper cell responses and promotes mixed granulocytic airway inflammation. | Mucosal Immunol | 2023 | 37209959 | PubTator, text mining | PubMed |
| New insights into the pathophysiology and therapeutic targets of asthma and comorbid chronic rhinosinusitis with or without nasal polyposis. | Clin Sci (Lond) | 2023 | 37199256 | PubTator, text mining | PubMed |
| Contribution to pathogenesis of accessory proteins of deadly human coronaviruses. | Front Cell Infect Microbiol | 2023 | 37197199 | PubTator, text mining | PubMed |
| The Impact of Different Types of Physical Effort on the Expression of Selected Chemokine and Interleukin Receptor Genes in Peripheral Blood Cells. | Cells | 2023 | 37190028 | PubTator, text mining | PubMed |
| T2-Low Asthma: A Discussed but Still Orphan Disease. | Biomedicines | 2023 | 37189844 | PubTator, text mining | PubMed |
| Mouse CCL9 Chemokine Acts as Tumor Suppressor in a Murine Model of Colon Cancer. | Curr Issues Mol Biol | 2023 | 37185750 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/23765/papers?page=29